scholarly article | Q13442814 |
P2093 | author name string | J Tan | |
D Morgan | |||
T Mori | |||
J Zeng | |||
F Fernandez | |||
H Hou | |||
Y Bai | |||
Deyan Luo | |||
T Town | |||
B Giunta | |||
D Obregon | |||
J Ehrhart | |||
W V Nikolic | |||
P2860 | cites work | Passive immunotherapy against Abeta in aged APP-transgenic mice reverses cognitive deficits and depletes parenchymal amyloid deposits in spite of increased vascular amyloid and microhemorrhage | Q24791704 |
CD40-CD40 ligand | Q28143324 | ||
Subacute meningoencephalitis in a subset of patients with AD after Abeta42 immunization | Q28185520 | ||
T-cell vaccination in multiple sclerosis: update on clinical application and mode of action | Q28271190 | ||
Structural and functional disruption of vascular smooth muscle cells in a transgenic mouse model of amyloid angiopathy | Q28359737 | ||
The immune responses in CD40-deficient mice: impaired immunoglobulin class switching and germinal center formation | Q28586300 | ||
Alzheimer's disease | Q29616743 | ||
Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse | Q29619237 | ||
Mechanisms of immunotherapeutic intervention by anti-CD40L (CD154) antibody in an animal model of multiple sclerosis | Q33835268 | ||
Immune hyporesponsiveness to amyloid beta-peptide in amyloid precursor protein transgenic mice: implications for the pathogenesis and treatment of Alzheimer's disease | Q33943122 | ||
Mutations of CD40 gene cause an autosomal recessive form of immunodeficiency with hyper IgM. | Q33947934 | ||
Human genetic defects in class-switch recombination (hyper-IgM syndromes). | Q34360486 | ||
CD40 signaling and Alzheimer's disease pathogenesis. | Q34386101 | ||
The hyper IgM syndrome | Q34561768 | ||
Nonviral Abeta DNA vaccine therapy against Alzheimer's disease: long-term effects and safety | Q34687112 | ||
CD40-CD40L interaction in Alzheimer's disease. | Q34750476 | ||
Normal Th1 development following long-term therapeutic blockade of CD154-CD40 in experimental autoimmune encephalomyelitis | Q34787127 | ||
The role of microglia in Alzheimer's disease: friend or foe? | Q34976952 | ||
A safer vaccine for Alzheimer's disease? | Q35019424 | ||
Regulation and function of class II major histocompatibility complex, CD40, and B7 expression in macrophages and microglia: Implications in neurological diseases | Q35022580 | ||
The CD40-CD154 interaction in B cell-T cell liaisons | Q35145640 | ||
Amyloid-beta vaccination, but not nitro-nonsteroidal anti-inflammatory drug treatment, increases vascular amyloid and microhemorrhage while both reduce parenchymal amyloid | Q35762247 | ||
Association of aortic atherosclerosis with cerebral beta-amyloidosis and learning deficits in a mouse model of Alzheimer's disease. | Q35843366 | ||
Transcutaneous beta-amyloid immunization reduces cerebral beta-amyloid deposits without T cell infiltration and microhemorrhage | Q35844472 | ||
Amyloid precursor protein processing and A beta42 deposition in a transgenic mouse model of Alzheimer disease | Q35998995 | ||
T-cells in Alzheimer's disease. | Q36295994 | ||
Expression of the activation marker urokinase plasminogen-activator receptor in cultured human central nervous system microglia | Q36827290 | ||
Peripheral anti-A beta antibody alters CNS and plasma A beta clearance and decreases brain A beta burden in a mouse model of Alzheimer's disease | Q37118356 | ||
Short amyloid-beta (Abeta) immunogens reduce cerebral Abeta load and learning deficits in an Alzheimer's disease mouse model in the absence of an Abeta-specific cellular immune response. | Q40328434 | ||
Activation of Toll-like receptor 2 on microglia promotes cell uptake of Alzheimer disease-associated amyloid beta peptide. | Q40341534 | ||
Peripherally administered antibodies against amyloid beta-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease | Q41753192 | ||
Identification of CD40 ligand in Alzheimer's disease and in animal models of Alzheimer's disease and brain injury | Q43832218 | ||
Neuronal zinc exchange with the blood vessel wall promotes cerebral amyloid angiopathy in an animal model of Alzheimer's disease. | Q44824312 | ||
Virus and virus-like particle-based immunogens for Alzheimer's disease induce antibody responses against amyloid-beta without concomitant T cell responses | Q45415101 | ||
Lipopolysaccharide-induced inflammation exacerbates tau pathology by a cyclin-dependent kinase 5-mediated pathway in a transgenic model of Alzheimer's disease. | Q46303283 | ||
Green tea epigallocatechin-3-gallate (EGCG) modulates amyloid precursor protein cleavage and reduces cerebral amyloidosis in Alzheimer transgenic mice. | Q46715173 | ||
Expression of CD40 in the brain of Alzheimer's disease and other neurological diseases | Q46847222 | ||
A beta peptide vaccination prevents memory loss in an animal model of Alzheimer's disease | Q47583762 | ||
Lipopolysaccharide-induced-neuroinflammation increases intracellular accumulation of amyloid precursor protein and amyloid beta peptide in APPswe transgenic mice | Q48196554 | ||
Evidence for peripheral clearance of cerebral Abeta protein following chronic, active Abeta immunization in PSAPP mice | Q48196624 | ||
Antibodies against beta-amyloid slow cognitive decline in Alzheimer's disease | Q48300537 | ||
Abeta40 inhibits amyloid deposition in vivo. | Q48305645 | ||
Inflammation and cerebral amyloidosis are disconnected in an animal model of Alzheimer's disease | Q48349951 | ||
Alzheimer disease's double-edged vaccine | Q48363044 | ||
Neuropathology of human Alzheimer disease after immunization with amyloid-beta peptide: a case report. | Q48363055 | ||
Vaccination with amyloid-beta peptide induces autoimmune encephalomyelitis in C57/BL6 mice | Q48404833 | ||
Reduced Th1 and enhanced Th2 immunity after immunization with Alzheimer's beta-amyloid(1-42). | Q48453604 | ||
Role of CD40 ligand in amyloidosis in transgenic Alzheimer's mice | Q48459353 | ||
Beta-amyloid deposition and Alzheimer's type changes induced by Borrelia spirochetes. | Q48886200 | ||
Co-expression of multiple transgenes in mouse CNS: a comparison of strategies | Q48889458 | ||
Disseminated cryptosporidium infection in an infant with hyper-IgM syndrome caused by CD40 deficiency. | Q51686248 | ||
Characterization of murine immunoglobulin G antibodies against human amyloid-beta1-42. | Q53242663 | ||
Microglial activation resulting from CD40-CD40L interaction after beta-amyloid stimulation. | Q53338394 | ||
CD40 signaling regulates innate and adaptive activation of microglia in response to amyloid beta-peptide. | Q53369015 | ||
Modulation of the humoral and cellular immune response in Abeta immunotherapy by the adjuvants monophosphoryl lipid A (MPL), cholera toxin B subunit (CTB) and E. coli enterotoxin LT(R192G). | Q54481541 | ||
Clinical spectrum of X-linked hyper-IgM syndrome | Q57075392 | ||
Antigen presentation by autoreactive proteolipid protein peptide-specific T cell clones from chronic progressive multiple sclerosis patients: roles of co-stimulatory B7 molecules and IL-12 | Q72997029 | ||
Patients with Alzheimer's disease display a pro-inflammatory phenotype | Q73405979 | ||
Microglia-mediated nitric oxide cytotoxicity of T cells following amyloid beta-peptide presentation to Th1 cells | Q73827793 | ||
CD45 inhibits CD40L-induced microglial activation via negative regulation of the Src/p44/42 MAPK pathway | Q74291010 | ||
Transformation of leech microglial cell morphology and properties following co-culture with injured central nervous system tissue | Q74447173 | ||
Amyloid-beta immunization effectively reduces amyloid deposition in FcRgamma-/- knock-out mice | Q78758456 | ||
CD154 plays a central role in regulating dendritic cell activation during infections that induce Th1 or Th2 responses | Q78762518 | ||
CD40 expression by microglial cells is required for their completion of a two-step activation process during central nervous system autoimmune inflammation | Q82310803 | ||
P433 | issue | 2 | |
P921 | main subject | cerebral amyloid angiopathy | Q191562 |
P304 | page(s) | 336-353 | |
P577 | publication date | 2007-10-16 | |
P1433 | published in | Neurobiology of Disease | Q15716606 |
P1476 | title | CD40L disruption enhances Abeta vaccine-mediated reduction of cerebral amyloidosis while minimizing cerebral amyloid angiopathy and inflammation | |
P478 | volume | 29 |